Takeda Pharmaceutical Company Limited Contingent Consideration Recognised As Of Acquisition Date
Takeda Pharmaceutical Company Limited (TKPHF) had Contingent Consideration Recognised As Of Acquisition Date of JPY 25.45 billion as of 2021-03-31, per its 20-F filed 2021-06-29.
Discontinued › Notes
ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate · last filed 2021-06-29
- 2021-03-31: Contingent Consideration Recognised As Of Acquisition Date 25.45B JPY.
- 2020-03-31: Contingent Consideration Recognised As Of Acquisition Date 92.52B JPY.
- 2019-03-31: Contingent Consideration Recognised As Of Acquisition Date 0.00 JPY.
| Period end | Contingent Consideration Recognised As Of Acquisition Date |
|---|---|
| 2021-03-31 | 25.45B JPY 20-F · filed 2021-06-29 |
| 2020-03-31 | 92.52B JPY 20-F · filed 2021-06-29 |
| 2019-03-31 | 0.00 JPY 20-F · filed 2020-06-24 |